From January 1, 2023 to March 31, 2023, the company has repurchased 60,000 shares, representing 0.14% for ¥126.08 million. With this, the company has completed the repurchase of 263,900 shares, representing 0.6% for ¥545.29 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,119 JPY | +1.00% | +3.01% | +5.06% |
Apr. 23 | Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints | CI |
Feb. 16 | Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.06% | 587M | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+14.56% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.